In the United States, where around 8 million people rely on insulin for diabetes management, soaring prices have created barriers to accessibility. As Congress takes initial steps to cap monthly ...
The rapid rise of biosimilars is reshaping retinal therapeutics, and manufacturing science is increasingly central to that shift. As Ashish Sharma, MD, a consultant in retinal research at the Lotus ...
Proposed transaction would seamlessly align with Sandoz strategic objective of capitalizing on projected USD 300 billion biosimilar market opportunity over next 10 years[1] Intended acquisition would ...
A biosimilar drug manufacturer is concentrating on process optimization to increase uptake of its products in lower-income countries. According to Jeffrey Hausfeld, MD, chairman of the board of ...
Despite Uptake Barriers, Real-World Biosimilar Data Demonstrate Safety, Efficacy, Cost-Effectiveness
Presenters explored the real-world evidence in support of biosimilars at the Academy of Managed Care Pharmacy 2024 annual meeting. Biosimilars were a recurring subject at the Academy of Managed Care ...
Providers and patients who want to understand biosimilars can now navigate through a new web app, that was created by Prime, and delivered in partnership with the AMCP Foundation and Biosimilars ...
This week, PharmTech took a look at the shift toward proactive, data-driven contamination control, the adoption of advanced material science to solve manufacturing hurdles, and an ...
Dr. Reddy’s Laboratories RDY announced that it has entered into a collaboration and license agreement with Alvotech ALVO to co-develop and commercialize a biosimilar candidate to Merck’s MRK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results